Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abilify in Bipolar I Depression
NCT00080314Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Jan 2004
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in bipolar I disorder, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Jan 2004; status: completed.
02
Drugs
aripiprazole
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00080314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080314.